echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Br J Dermatol: Suckinumab shows potent and durable efficacy in nail psoriasis

    Br J Dermatol: Suckinumab shows potent and durable efficacy in nail psoriasis

    • Last Update: 2022-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com




    Chi-square test showed a correlation between nail clearance (mNAPSI ≤ 2) at 52 weeks and cutaneous and musculoskeletal outcomes such as Psoriasis Area and Severity Index 90, resolution of terminal inflammation, resolution of dactylitis, health assessment questionnaire - Disability index (shrinkage >0.


     

    Figure 1.





    Source: Reich K, Baraliakos X, Coates LC, Secukinumab demonstrates high and sustained efficacy in nail psoriasis: Post hoc analysis from phase 3 trials in patients with psoriatic arthritis.




    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.